About Barts and The London School of Medicine and Dentistry
Barts and The London School of Medicine and Dentistry is part of Queen Mary, University of London.
Barts and The London offers international levels of excellence in research and teaching while serving a population of unrivalled diversity.
Through partnership with our linked trusts, notably Barts Health NHS Trust, and our associated University Hospital Trusts – Homerton, Newham, Whipps Cross and Queen’s (Romford) the School’s research and teaching is informed by an exceptionally wide ranging and stimulating clinical environment.
In Spring 2014 the School of Dentistry in moved into brand new premises, The Royal London Dental Hospital. Watch our short film showcasing the technology, learning and research within the new Dental School.
At the heart of the School’s mission lies world class research, the result of a focused programme of recruitment of leading research groups from the UK and abroad and a £100 million investment in state-of-the-art facilities.
Research is focused on translational research, cancer, cardiac, dentistry, inflammation, endocrinology/ metabolism, immunology and infectious diseases, genomics, neuroscience, gastroenterology, epidemiology and primary care.
The School is nationally and internationally recognised for research in these areas, reflected in the £40 million it attracts annually in research income. Its fundamental mission, with its partner NHS Trusts, and other partner organisations, such as CR-UK, is to ensure that that the best possible clinical service is underpinned by the very latest developments in scientific and clinical teaching, training and research.
The School is organised into the following Institutes:
- Barts Cancer Institute
- Blizard Institute of Cell and Molecular Science
- Institute of Health Sciences Education
- Institute of Dentistry
- William Harvey Research Institute
- Wolfson Institute of Preventive Medicine
The School is also home to the first Cancer Research UK Clinical Centre to be established which takes an innovative 'molecules to patient' approach to research.